Oesophagectomy after Definitive Chemoradiation in Patients with Locally Advanced Oesophageal Cancer

Clinical Oncology

Volumn 20, Issue 3, 2008, Pages 221-226

  Borghesi, S ^a   Hawkins, M A ^a   Tait, D ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Chemoradiation; follow up; oesophageal cancer; oesophagectomy

Indexed keywords

CAPECITABINE; CISPLATIN; EPIRUBICIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; EMPHYSEMA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; MULTIPLE CYCLE TREATMENT; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIATION DOSE; REPEATED DRUG DOSE; RETROSPECTIVE STUDY; SALVAGE THERAPY; SEPSIS; SURVIVAL RATE; SURVIVAL TIME; TREATMENT DURATION; TREATMENT FAILURE; UNITED KINGDOM;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DEOXYCYTIDINE; EPIRUBICIN; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 40649089058     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2007.12.001     Document Type: Article

References (37)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 2 (2005) 74-108
2. Hulscher J.B., Tijssen J.G., Obertop H., and van Lanschot J.J. Transthoracic versus transhiatal resection for carcinoma of the oesophagus: a meta-analysis. Ann Thorac Surg 72 1 (2001) 306-313
3. Herskovic A., Martz K., Al-Sarraf M., et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the oesophagus. N Engl J Med 326 24 (1992) 1593-1598
4. Cooper J.S., Guo M.D., Herskovic A., et al. Chemoradiotherapy of locally advanced oesophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 281 17 (1999) 1623-1627
5. Al-Sarraf M., Martz K., Herskovic A., et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with oesophageal cancer: an intergroup study. J Clin Oncol 15 1 (1997) 277-284
6. Urschel J.D., and Sellke F.W. Complications of salvage oesophagectomy. Med Sci Monit 9 7 (2003) RA173-RA180
7. Urschel J.D., Ashiku S., Thurer R., and Sellke F.W. Salvage or planned oesophagectomy after chemoradiation therapy for locally advanced oesophageal cancer - a review. Dis Oesophagus 16 2 (2003) 60-65
8. Murakami M., Kuroda Y., Takeda H., et al. Case report of 14-year survival after radiotherapy for clinical T3 oesophageal carcinoma, with local recurrence finally rescued by surgery. Radiat Med 17 6 (1999) 459-462
9. In: Ries L.A.G., Eisner M.P., Kosary C., et al. (Eds). SEER cancer statistic review, 1973-1999 (2002), National Cancer Institute, Bethesda
10. Minsky B.D., Pajak T.F., Ginsberg R.J., et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for oesophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20 5 (2002) 1167-1174
11. Apinop C., Puttisak P., and Preecha N. A prospective study of combined therapy in oesophageal cancer. Hepatogastroenterology 41 (1994) 391-393
12. Burmeister B.H., Smithers B.M., Fitzgerald L., et al. A randomized phase III trial of preoperative chemoradiation followed by surgery (CR-S) versus surgery alone (S) for localized resectable cancer of the oesophagus. Prog Proc Am Soc Clin Oncol 21 (2002) 130a
13. Law S., Kwong D., Tung H., et al. Preoperative chemoradiation for squamous cell oesophageal cancer: a prospective randomized trial. Can J Gastroenterol 12 Suppl B (1998) 56B
14. Bosset J.-F., Gignoux M., Triboulet J.-P., et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the oesophagus. N Engl J Med 337 (1997) 161-167
15. Urba S.G., Orringer M.B., Turrisi A., Iannettoni M., Forastiere A., and Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with loco-regional oesophageal carcinoma. J Clin Oncol 19 (2001) 305-313
16. Nygaard K., Hagen S., Hansen H.S., et al. Pre-operative radiotherapy prolongs survival in operable oesophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy: the second Scandinavian trial in oesophageal carcinoma. World J Surg 16 (1992) 1104-1110
17. Stahl M., Stuschke M., Lehmann N., et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the oesophagus. J Clin Oncol 23 10 (2005) 2310-2317
18. Le Prise E., Etienne P.L., Meunier B., et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the oesophagus. Cancer 73 (1994) 1179-1184
19. Swisher S.G., Wynn P., Putnam J.B., et al. Salvage oesophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg 123 1 (2002) 175-183
20. Tomimaru Y., Yano M., Takachi K., et al. Factors affecting the prognosis of patients with oesophageal cancer undergoing salvage surgery after definitive chemoradiotherapy. J Surg Oncol 93 5 (2006) 422-428
21. Meunier B., Raoul J., Le Prise E., Lakehal M., and Launois B. Salvage oesophagectomy after unsuccessful curative chemoradiotherapy for squamous cell cancer of the oesophagus. Dig Surg 15 3 (1998) 224-226
22. Muro K., Najima M., Hamaguchi T., et al. Definitive chemoradiotherapy followed by salvage therapy for loco-regional failure might be a standard treatment option for stages I-III oesophageal squamous cell carcinoma. J Clin Oncol 23 16S (2005) 4069 [Part I of II (June 1 Supplement)]
23. Eloubeidi M.A., Desmond R., Arguedas M.R., Reed C.E., and Wilcox C.M. Prognostic factors for the survival of patients with oesophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer 95 7 (2002) 1434-1443
24. Nakamura T., Hayashi K., Ota M., et al. Salvage oesophagectomy after definitive chemotherapy and radiotherapy for advanced oesophageal cancer. Am J Surg 188 3 (2004) 261-266
25. Gotohda N., Nishimura M., Yoshida J., Nagai K., Boku N., and Ohtsu A. Salvage operation for oesophageal cancer after radical chemoradiotherapy. Kyobu Geka 55 9 (2002) 743-746 [discussion 746-749]
26. Bonnetain F., Bouche O., Michel P., et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic oesophageal cancer. Ann Oncol 17 5 (2006) 827-834
27. Stahl M., Kataja V.V., and Oliveira J. ESMO Guidelines Task Force. ESMO Minimal Clinical Recommendations for diagnosis, treatment and follow-up of oesophageal cancer. Ann Oncol 16 Suppl 1 (2005) i26-i27
28. Triboulet J.P., Amrouni H., Guillem P., Vandenhaute B., Lecomte-Houcke M., and Adenis A. Long term results of oesophageal epidermoid cancers in complete remission after preoperative chemo-radiotherapy. Ann Chir 52 6 (1998) 503-508
29. Shaukat A., Mortazavi A., Demmy T., et al. Should preoperative, post-chemoradiotherapy endoscopy be routine for oesophageal cancer patients?. Dis Oesophagus 17 2 (2004) 129-135
30. Jones D.R., Detterbeck F.C., Egan T.M., Parker Jr. L.A., Bernard S.A., and Tepper J.E. Induction chemoradiotherapy followed by oesophagectomy in patients with carcinoma of the oesophagus. Ann Thorac Surg 64 1 (1997) 185-191
31. Lim J.T., Truong P.T., Berthelet E., et al. Endoscopic response predicts for survival and organ preservation after primary chemoradiotherapy for oesophageal cancer. Int J Radiat Oncol Biol Phys 57 5 (2003) 1328-1335
32. Beseth B.D., Bedford R., Isacoff W.H., Holmes E.C., and Cameron R.B. Endoscopic ultrasound does not accurately assess pathologic stage of oesophageal cancer after neoadjuvant chemoradiotherapy. Am Surg 66 9 (2000) 827-831
33. Rice T.W., Boyce G.A., Sivak M.V., Adelstein D.J., and Kirby T.J. Oesophageal carcinoma: oesophageal ultrasound assessment of preoperative chemotherapy. Ann Thorac Surg 53 6 (1992) 972-977
34. Chak A., Canto M.I., Cooper G.S., et al. Endosonographic assessment of multimodality therapy predicts survival of oesophageal carcinoma patients. Cancer 88 8 (2000) 1788-1795
35. Westerterp M., Van Westreenen H.L., Reitsma J.B., et al. Oesophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy systematic review. Radiology 236 3 (2005) 841-851
36. Flamen P., Van Cutsem E., Lerut A., et al. Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer. Ann Oncol 13 3 (2002) 361-368
37. Munden R.A., Macapinlac H.A., and Erasmus J.J. Oesophageal cancer: the role of integrated CT-PET in initial staging and response assessment after preoperative therapy. J Thorac Imaging 21 2 (2006) 137-145